Merck & Co., Inc. Equity Securities, FV-NI, Unrealized Gain
Merck & Co., Inc. (MRK) reported Equity Securities, FV-NI, Unrealized Gain of -$39.00 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGain · last filed 2019-08-06
- Merck & Co., Inc. equity securities, fv-ni, unrealized gain for the quarter ending 2019-06-30 was -$39.00M, a 657.14% decline year-over-year.
- Merck & Co., Inc. equity securities, fv-ni, unrealized gain for the quarter ending 2019-03-31 was $114.00M, a 159.09% increase year-over-year.
- Merck & Co., Inc. equity securities, fv-ni, unrealized gain for the quarter ending 2018-09-30 was $10.00M.
- Merck & Co., Inc. equity securities, fv-ni, unrealized gain for the quarter ending 2018-06-30 was $7.00M.
| Period end | Equity Securities, FV-NI, Unrealized Gain 3 month | Equity Securities, FV-NI, Unrealized Gain 6 month | Equity Securities, FV-NI, Unrealized Gain 9 month |
|---|---|---|---|
| 2019-06-30 | -$39.00M 10-Q · filed 2019-08-06 | $75.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $114.00M 10-Q · filed 2019-05-08 | ||
| 2018-09-30 | $10.00M 10-Q · filed 2018-11-06 | $17.00M derived: sum of 2 quarters · filed 2019-08-06 | $60.00M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $7.00M 10-Q · filed 2019-08-06 | $50.00M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $44.00M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |